Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14980564 | 0.80 | HSD17B10 (0.41) | BLMPMP22HSD17B10CA12CA1 | |
| SCHEMBL20438513 | 0.79 | OPRM1 (0.35) | BLMPMP22HSD17B10PIK3CDMEN1 | |
| SCHEMBL19554740 | 0.79 | ALDH1A1 (0.37) | BLMPMP22HSD17B10PIK3CDCA12 | |
| SCHEMBL20445520 | 0.78 | PIK3CD (0.33) | PIK3CD | |
| SCHEMBL20438697 | 0.77 | BLM (0.33) | BLMPMP22HSD17B10PIK3CDMEN1 | |
| SCHEMBL11816356 | 0.77 | PIK3CD (0.38) | PIK3CDCYP1A2MAPK1CA12CA1 | |
| SCHEMBL20438708 | 0.77 | HSD17B10 (0.38) | BLMPMP22HSD17B10MEN1POLB | |
| SCHEMBL20445521 | 0.77 | PIK3CD (0.32) | PIK3CD | |
| SCHEMBL23634754 | 0.77 | MEN1 (0.41) | PIK3CDCYP1A2MAPK1MEN1POLB | |
| SCHEMBL15016045 | 0.76 | CYP1A2 (0.48) | PIK3CDCYP1A2MAPK1CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10590264-B2 | Photopolymerization initiator, polymerizable composition, ink jet recording method, and acylphosphine oxide compound | FUJIFILM CORPORATION (JP) | 2020-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10590264-B2 | Photopolymerization initiator, polymerizable composition, ink jet recording method, and acylphosphine oxide compound | CCNT1, CDK1, CCNB1 | BLM 2972/4885PMP22 3029/4885HSD17B10 3572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.